vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $18.9M, roughly 1.5× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -18.0%, a 32.6% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 16.7%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
ELMD vs MSS — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $27.6M |
| Net Profit | $2.8M | $-5.0M |
| Gross Margin | 78.4% | 23.4% |
| Operating Margin | 19.2% | -4.9% |
| Net Margin | 14.6% | -18.0% |
| Revenue YoY | 16.3% | -10.9% |
| Net Profit YoY | 40.3% | -1840.5% |
| EPS (diluted) | $0.32 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $27.6M | ||
| Q3 25 | $16.9M | $27.2M | ||
| Q2 25 | $17.4M | $34.4M | ||
| Q1 25 | $15.7M | $32.3M | ||
| Q4 24 | $16.3M | $29.4M | ||
| Q3 24 | $14.7M | $28.2M | ||
| Q2 24 | $14.8M | $16.9M | ||
| Q1 24 | $13.9M | $13.6M |
| Q4 25 | $2.8M | $-5.0M | ||
| Q3 25 | $2.1M | $-1.5M | ||
| Q2 25 | $2.2M | $-287.4K | ||
| Q1 25 | $1.9M | $1.0M | ||
| Q4 24 | $2.0M | $-256.0K | ||
| Q3 24 | $1.5M | $700.9K | ||
| Q2 24 | $1.8M | $-2.8M | ||
| Q1 24 | $1.5M | $-549.0K |
| Q4 25 | 78.4% | 23.4% | ||
| Q3 25 | 78.1% | 24.1% | ||
| Q2 25 | 78.3% | 9.5% | ||
| Q1 25 | 78.0% | 21.8% | ||
| Q4 24 | 77.7% | 26.9% | ||
| Q3 24 | 78.3% | 28.9% | ||
| Q2 24 | 76.2% | 13.0% | ||
| Q1 24 | 74.8% | 23.4% |
| Q4 25 | 19.2% | -4.9% | ||
| Q3 25 | 15.8% | 0.7% | ||
| Q2 25 | 17.5% | -15.9% | ||
| Q1 25 | 13.6% | 3.7% | ||
| Q4 24 | 15.6% | 3.2% | ||
| Q3 24 | 13.2% | 7.3% | ||
| Q2 24 | 15.7% | -14.4% | ||
| Q1 24 | 13.3% | -2.3% |
| Q4 25 | 14.6% | -18.0% | ||
| Q3 25 | 12.6% | -5.7% | ||
| Q2 25 | 12.7% | -0.8% | ||
| Q1 25 | 12.1% | 3.1% | ||
| Q4 24 | 12.1% | -0.9% | ||
| Q3 24 | 10.0% | 2.5% | ||
| Q2 24 | 12.3% | -16.4% | ||
| Q1 24 | 10.8% | -4.0% |
| Q4 25 | $0.32 | $-0.23 | ||
| Q3 25 | $0.25 | $-0.08 | ||
| Q2 25 | $0.26 | $-0.02 | ||
| Q1 25 | $0.21 | $0.06 | ||
| Q4 24 | $0.22 | $-0.01 | ||
| Q3 24 | $0.16 | $0.04 | ||
| Q2 24 | $0.20 | $-0.16 | ||
| Q1 24 | $0.17 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $45.4M | $11.6M |
| Total Assets | $54.9M | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $14.1M | $1.1M | ||
| Q2 25 | $15.3M | $775.4K | ||
| Q1 25 | $15.2M | $445.4K | ||
| Q4 24 | $16.2M | $355.7K | ||
| Q3 24 | $13.9M | $588.9K | ||
| Q2 24 | $16.1M | $2.1M | ||
| Q1 24 | $11.7M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $45.4M | $11.6M | ||
| Q3 25 | $44.7M | $10.1M | ||
| Q2 25 | $43.2M | $11.7M | ||
| Q1 25 | $43.9M | $12.0M | ||
| Q4 24 | $43.6M | $10.9M | ||
| Q3 24 | $41.5M | $11.2M | ||
| Q2 24 | $44.5M | $10.5M | ||
| Q1 24 | $42.5M | $13.3M |
| Q4 25 | $54.9M | $75.4M | ||
| Q3 25 | $53.6M | $73.3M | ||
| Q2 25 | $53.8M | $77.4M | ||
| Q1 25 | $52.5M | $82.7M | ||
| Q4 24 | $52.3M | $82.7M | ||
| Q3 24 | $48.9M | $82.1M | ||
| Q2 24 | $52.2M | $82.4M | ||
| Q1 24 | $48.9M | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $-1.7M |
| Free Cash FlowOCF − Capex | $2.4M | — |
| FCF MarginFCF / Revenue | 12.7% | — |
| Capex IntensityCapex / Revenue | 3.4% | — |
| Cash ConversionOCF / Net Profit | 1.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $-1.7M | ||
| Q3 25 | $169.0K | $1.1M | ||
| Q2 25 | $3.9M | $-1.6M | ||
| Q1 25 | $2.1M | $1.7M | ||
| Q4 24 | $3.2M | $1.1M | ||
| Q3 24 | $2.3M | $3.6M | ||
| Q2 24 | $4.5M | $-2.6M | ||
| Q1 24 | $1.4M | $-1.4M |
| Q4 25 | $2.4M | — | ||
| Q3 25 | $-83.0K | — | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $4.5M | — | ||
| Q1 24 | $1.3M | — |
| Q4 25 | 12.7% | — | ||
| Q3 25 | -0.5% | — | ||
| Q2 25 | 21.4% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 15.5% | — | ||
| Q2 24 | 30.1% | — | ||
| Q1 24 | 9.1% | — |
| Q4 25 | 3.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 1.75× | — | ||
| Q1 25 | 1.10× | 1.66× | ||
| Q4 24 | 1.60× | — | ||
| Q3 24 | 1.57× | 5.12× | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 0.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
